Citrate Synthase Start Codon Modification for L-Lysine Productivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for enhancing L-lysine productivity in Corynebacterium glutamicum strains, such as gene recombination and enzyme expression manipulation, do not effectively control the metabolic flux of oxaloacetate to citrate, limiting L-lysine production efficiency.
Innovation Solution
Modifying the start codon of the citrate synthase gene from ATG to GTG or TTG in Corynebacterium glutamicum strains to weaken citrate synthase activity, thereby reducing the conversion of oxaloacetate to citrate and increasing L-lysine production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Use of energy by moving object
If citrate synthase activity is increased to enhance metabolic flux through the TCA cycle, then energy production is improved, but L-lysine productivity decreases due to excessive conversion of oxaloacetate to citrate
Solution Approach 1:
The invention changes the genetic parameters of citrate synthase by replacing the start codon ATG with GTG or TTG, which alters the translation efficiency and reduces enzyme activity. This parameter change in the gene sequence directly controls the metabolic flux distribution, allowing oxaloacetate to be directed toward L-lysine synthesis rather than being converted to citrate, thereby resolving the contradiction between energy production and L-lysine productivity
Solution Approach 2:
The invention applies partial action by not completely eliminating citrate synthase activity but rather reducing it to an optimal level. The weakened enzyme activity is sufficient to redirect metabolic flux toward L-lysine production while maintaining adequate energy production, achieving the desired balance without complete inhibition of the TCA cycle
2Productivity
If gene recombination technology is applied to enhance L-lysine productivity, then production efficiency is improved, but metabolic flux control of oxaloacetate to citrate conversion remains insufficient
Solution Approach 1:
The invention extracts and specifically targets the citrate synthase gene (gltA) as the key control point in the metabolic pathway. By focusing genetic modification efforts on this single gene and replacing its start codon, the invention achieves precise control over the oxaloacetate to citrate conversion step, thereby improving overall L-lysine productivity through targeted metabolic flux control
3Speed
If oxaloacetate conversion to citrate is enhanced, then TCA cycle activity is improved, but L-lysine precursor availability decreases
Solution Approach 1:
Instead of enhancing oxaloacetate conversion to citrate as conventionally done, the invention inverts the approach by reducing this conversion through citrate synthase gene modification. This inversion allows oxaloacetate to accumulate and be redirected toward L-lysine synthesis, simultaneously maintaining TCA cycle activity at an optimal level for overall cellular function
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in a 5-20% increase in L-lysine productivity, achieving yields of 66-80 g/L, by optimizing the metabolic pathway and enhancing carbon source efficiency.
Implementation Method 1
citrate synthase that converts oxaloacetate to citrate
Data Source
AI summary
The present disclosure relates to a Corynebacterium glutamicum mutant strain having enhanced L-lysine productivity and a method of producing L-lysine using the same. The Corynebacterium glutamicum mutant strain may produce L-lysine in an improved yield by inhibiting the conversion of oxaloacetate to citrate due to decreased or inhibited expression of the gene encoding the citrate synthase.